De-Shaine Murray is a Wu Tsai Institute Postdoctoral Fellow who focuses on developing sensors and devices to monitor the injured brain. With the Saltzman lab, he is creating a drug delivery device for the intrathecal administration of nanoparticles to treat brain cancers such as medulloblastoma.
In his previous research De-Shaine investigated the creation of new devices to chemically and electrically monitor the injured brain, working in the Biomedical sensors group at Imperial College London led by Martyn Boutelle and the Bioelectronics group in Cambridge led by George Malliaras. In 2022, he completed his Ph.D. with a thesis on “OneProbe: Development of a new flexible, microfabricated device for non-penetrative, multimodal monitoring of the injured brain.